Kidney involvement in patients with systemic lupus erythematosus—lupus nephritis (LN)—is
one of the most important and common clinical manifestations of this disease and occurs in …

Developmental and epileptic encephalopathies are rare, treatment-resistant epilepsies with
high seizure burden and non-seizure comorbidities. The antiseizure medication (ASM) …

Fibrotic diseases, such as systemic sclerosis (SSc), idiopathic pulmonary fibrosis, renal
fibrosis and liver cirrhosis are characterized by tissue overgrowth due to excessive …

Lupus nephritis (LN) is an autoimmune disease with multiple system involvement and is also
one of the most serious forms of organ damage in systemic lupus erythematosus (SLE) …

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with a broad
spectrum of clinical manifestations. The proposed pathophysiological hypotheses of SLE are …

Lupus nephritis (LN) is a significant cause of various acute and chronic renal diseases,
which can eventually lead to end-stage renal disease. The pathogenic mechanisms of LN …

microRNA-146a (miR-146a) plays an essential role in immune anomalies and organ injury
of systemic lupus erythematosus (SLE) by regulating the disease's inflammation and …

Lupus nephritis (LN) is one of the most severe complications in patients with systemic lupus
erythematosus (SLE). Traditionally, LN is regarded as an immune complex (IC) deposition …

T-helper cytokines interferon gamma (IFNɣ), interleukin 17 (IL-17) and IL-10 impact
systemic lupus erythematosus (SLE) directly and indirectly via modulation of autoAb …

Systemic lupus erythematosus (SLE) is characterized by the breakdown of self-tolerance,
the production of high-affinity pathogenic autoantibodies and derailed B cell responses …